Wall Street Analysts See a 126.21% Upside in Immuneering (IMRX): Can the Stock Really Move This High?

Shares of Immuneering Corporation (IMRX) have gained 14.6% over the past four weeks to close the last trading session at $7.44, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $16.83 indicates a potential upside of 126.2%.The average comprises six short-term price targets ranging from a low of $11.00 to a high of $30.00, with a standard deviation of $7.19. While the lowest estim ...